Joshua N. Silverman - 12 Dec 2025 Form 4 Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Role: CEO and President, Director
Signature: /s/ Joshua N. Silverman
Issuer symbol: PMCB
Transactions as of: 12 Dec 2025
Net transactions value: -$263,925
Form type: 4
Filing time: 12 Dec 2025, 17:07:33 UTC
Previous filing: 14 Nov 2025
Next filing: 02 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Silverman Joshua	CEO and President, Director	C/O PHARMACYTE BIOTECH, INC., 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS	/s/ Joshua N. Silverman	12 Dec 2025	0001524858

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PMCB	Common Stock	Award	$0	+575,000		$0.000000	575,000	12 Dec 2025	Direct
transaction	PMCB	Common Stock	Tax liability	$263,925	-258,750	-45%	$1.02	316,250	12 Dec 2025	Direct	F1
holding	PMCB	Common Stock						50,000	12 Dec 2025	JNS Holdings Group LLC

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.